Citadel Advisors
EPRX

Citadel Advisors’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Citadel Advisors’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$108K Buy
18,236
+6,182
+51% +$36.6K ﹤0.01% 5243
2025
Q1 		$39.4K Buy
+12,054
New +$39.4K ﹤0.01% 5430